Abstract

The Role of Histone H3-K27M Mutation in Preleukemic HSC Expansion

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Identification of a differentiation stall in epithelial mesenchymal transition in histone H3-mutant diffuse midline glioma.
Sofie R Salama ... Holly C Beale
GigaScience | VOL. 9
Sofie R Salama, et. al.Sofie R Salama ... Holly C Beale
15 Dec 2020
Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.
Fabrice Chrétien ... Jacques Grill
Brain pathology (Zurich, Switzerland) | VOL. 28
Fabrice Chrétien, et. al.Fabrice Chrétien ... Jacques Grill
08 Feb 2017
Differentiation between spinal cord diffuse midline glioma with histone H3 K27M mutation and wild type: comparative magnetic resonance imaging
Seong Yi ... Sung Soo Ahn
Neuroradiology | VOL. 61
Seong Yi, et. al.Seong Yi ... Sung Soo Ahn
20 Jan 2019
Four methods to analyze H3K27M mutation in diffuse midline gliomas
Bing Xue ... Xiao Fang
Pathology - Research and Practice | VOL. 216
Bing Xue, et. al.Bing Xue ... Xiao Fang
18 Jun 2020
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia.
Luisa Corrêa De Araujo Koury ... Eduardo M Rego
Blood | VOL. -
Luisa Corrêa De Araujo Koury, et. al.Luisa Corrêa De Araujo Koury ... Eduardo M Rego
28 May 2024
Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of cell cycle.
Carys S Johnson ... Elisa Laurenti
Blood | VOL. -
Carys S Johnson, et. al.Carys S Johnson ... Elisa Laurenti
28 May 2024
CD20-bispecific antibodies improve response to CD19-CAR T-cells in lymphoma in-vitro and CLL in-vivo models.
Berit J Brinkmann ... Sascha Dietrich
Blood | VOL. -
Berit J Brinkmann, et. al.Berit J Brinkmann ... Sascha Dietrich
28 May 2024
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies
Matthew J Frigault ... Marcela V Maus
Blood | VOL. -
Matthew J Frigault, et. al.Matthew J Frigault ... Marcela V Maus
23 May 2024
View more papers